Immunebridge
Developing allogeneic immunotherapies for cancer
Operating in nfx portfolio, Immunebridge was founded in 2018.
Its activity falls under nfx portfolio; the profile below is assembled from public directory data.
Directory data places it at the Seed stage.
| Sector | NFX portfolio |
|---|---|
| Founded | 2018 |
| Stage | Seed |
Website: www.immunebridge.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account